about
Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failureKinetics of plasma SPB and RAGE during mechanical ventilation in patients undergoing major vascular surgeryCardiovascular risk assessment in low-resource settings: a consensus document of the European Society of Hypertension Working Group on Hypertension and Cardiovascular Risk in Low Resource SettingsAcute high-altitude exposure reduces lung diffusion: data from the HIGHCARE Alps project.Prognostic role of atrial fibrillation in patients affected by chronic heart failure. Data from the MECKI score research group.Effects of hypobaric hypoxia exposure at high altitude on left ventricular twist in healthy subjects: data from HIGHCARE study on Mount Everest.The metabolic exercise test data combined with Cardiac And Kidney Indexes (MECKI) score and prognosis in heart failure. A validation study.Exercise tolerance can explain the obesity paradox in patients with systolic heart failure: data from the MECKI Score Research Group.High-altitude hypoxia and periodic breathing during sleep: gender-related differences.Systemic to pulmonary bronchial blood flow in heart failure.Interleukin-1β levels predict long-term mortality and need for heart transplantation in ambulatory patients affected by idiopathic dilated cardiomyopathy.Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing total loss of lipase activity in a patient with myopathy and slight cardiac involvement.Redox proteomics identification of oxidatively modified myocardial proteins in human heart failure: implications for protein function.Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis.Isolated ultrafiltration in moderate congestive heart failure.Comparison of the diagnostic performance of 64-slice computed tomography coronary angiography in diabetic and non-diabetic patients with suspected coronary artery diseaseEffects of slow deep breathing at high altitude on oxygen saturation, pulmonary and systemic hemodynamicsSustained benefit from ultrafiltration in moderate congestive heart failure.Surfactant-derived proteins as markers of alveolar membrane damage in heart failure.Inside ventilatory regulation in pulmonary hypertension: several hidden data are still undiscovered.Effects of blood transfusion on exercise capacity in thalassemia major patients.Cardiopulmonary interaction in heart failure.Prognostic value of multidetector computed tomography coronary angiography in diabetes: excellent long-term prognosis in patients with normal coronary arteriesPrognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure.Noninvasive measurement of cardiac output during exercise by inert gas rebreathing technique.Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation.A non invasive estimate of dead space ventilation from exercise measurements.Respiratory effects of beta-blocker therapy in heart failure.Extracorporeal fluid removal in heart failure patients.Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure.Exercise testing in the clinical management of patients affected by pulmonary arterial hypertension.Considerations on safety and treatment of patients with chronic heart failure at high altitude.Predicted values of exercise capacity in heart failure: where we are, where to go.Management of heart failure in the new era: the role of scores.Ultrafiltration for congestive heart failure: the past and the present.Continuous ultrafiltration in acute decompensated heart failure: current issues and future directions.Renin-Angiotensin-Aldosterone System Is Not Involved in the Arterial Stiffening Induced by Acute and Prolonged Exposure to High Altitude.Ambulatory blood pressure in untreated and treated hypertensive patients at high altitude: the High Altitude Cardiovascular Research-Andes study.The patient perspective: Quality of life in advanced heart failure with frequent hospitalisations.ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism.
P50
Q28176355-2A4E981B-553E-4229-AB83-6BBEB54CDB64Q28242672-18834677-21B8-4357-89BF-B584C193C476Q30391917-A622DEA7-B8AD-4F79-BF16-5DD4E3D89B4BQ30619949-8E1F6B5A-6021-4870-B76F-095199B1D35BQ30961727-546DB404-B13B-4AED-A63B-D20C859ACBE6Q30978544-00F4E777-56A1-4F2D-9D2D-FB01DD7CF59EQ31030359-B4F5FF81-EE39-4FD3-97AB-7C240C3EEB71Q31089116-A63EC21E-5350-4B43-92C8-0D4F2C51F2CCQ33456807-F4AF42E3-35D4-4E3F-B3C2-A43338562B3BQ33484179-B176B17F-BE4B-4E07-B34F-A46E41A39B27Q33648781-12A2DD62-9B6A-42CC-AF85-C45C88EB7139Q33656924-79ACFF2A-4CFE-4CBB-B2F1-617BD90A5BB7Q34273494-2BD7DEAF-32BD-4662-B844-56BBD416A246Q34337289-6F3616EF-28E9-40EA-B297-069568C034CBQ34359735-D9078BA3-1099-47F6-BF5C-1CB3E9EC8951Q34426619-69EF3696-813B-485F-9EC8-EE32D231BF8FQ34477709-FC05E5C9-B1F4-453F-9092-03FAD8D5E944Q34502959-BA135B5C-0A19-4E1B-8468-E29A57F106EEQ34712791-CE123869-E71E-411B-BA2D-F94E1E098E42Q34830294-A055BAD7-1439-4375-A18E-0C7940981397Q35641346-E588B2F8-4E68-43E6-953E-D23A3004F69FQ36479465-FE2A772B-04F7-4FD0-B635-F3CA47406FDBQ36942074-3B299876-5888-4EA6-93CF-11078E551B88Q36965403-339ED129-659F-472F-B088-320B1B7860E6Q37403346-396F65A6-6063-4313-A84C-05582435D0F7Q37480687-9758FAA8-43BC-44BD-B343-7FEAFB19EE72Q37534626-BA0DA82B-7E7A-4D01-A2E5-4224349D4B0CQ37605622-B6BEE729-96E5-41CE-871F-40A90B54CD31Q37739156-3E425B79-0FAA-41C2-8207-14CB24FFAE91Q37801830-F63E6C04-3FB8-4CB5-83B4-29987DF19BC6Q38057752-EFA58DB7-54D8-4A1D-9C52-0ABFD3C0C1DEQ38116545-D1967AD5-08ED-41ED-9F51-DE2B3D4CE25FQ38128720-8D893B76-9DB1-44C6-9994-CD70719036EAQ38235976-BF291EAC-4B55-4123-9CC2-ED67E07F3C03Q38312848-BFA8E32A-6714-4CCE-A0E6-C291A09BC9D9Q38343671-734AA8FC-C2AA-4E47-9046-64E815914106Q38376001-DE7EFC5A-96C7-41A5-8B63-09F0ABE07BB1Q38412801-A4FCDF3A-0456-4FD9-811D-DDC60083BF63Q38485131-AE719247-A98D-4AAB-ABA0-689B3760A5D8Q38656360-CA7C2435-386B-4461-9D80-D6341CBB614D
P50
description
researcher ORCID ID = 0000-0002-8345-6382
@en
wetenschapper
@nl
name
Piergiuseppe Agostoni
@ast
Piergiuseppe Agostoni
@en
Piergiuseppe Agostoni
@es
Piergiuseppe Agostoni
@nl
type
label
Piergiuseppe Agostoni
@ast
Piergiuseppe Agostoni
@en
Piergiuseppe Agostoni
@es
Piergiuseppe Agostoni
@nl
prefLabel
Piergiuseppe Agostoni
@ast
Piergiuseppe Agostoni
@en
Piergiuseppe Agostoni
@es
Piergiuseppe Agostoni
@nl
P31
P496
0000-0002-8345-6382